Safety analysis of robotic right-hemicolectomy for right sided colon cancer

Ishibe Atsushi0 个研究点目标入组 42 人开始时间: 2021年7月14日最近更新: 2024年4月23日

适应症

试验速览

This study demonstrated the safety and feasibility of robotic surgery for right-sided colon cancer.

•1. Patients over 20 years old age
•2. Histologically, diagnosed with colon cancer
•3. Preoperative diagnosis of curative primary resection
•4. Main tumor site is cecum (C), ascending colon (A) or right-sided transverse colon (T) and right-hemicolectomy with D2 or higher lymph node dissection is pre-planned
•5. Clinical stage I to IIIC (T1-4b, N0-2b, M0: TNM Classification) has been diagnosed
•6. Patients who are diagnosed out of the endoscopic resection
•7. Patients with tumor maximum diameter of 8 cm or less
•8. Patients who do not recognize multiple lesions that require two or more anastomosis places
•9. Patients with ECOG Performance Status (PS) score of 0 to 1
•10. Patients who have the judgment to fully understand the research content.
•11. Patients with written informed consent to participate in this study.

•1. Patients with chemotherapy (systemic anti-cancer drug treatment) and a history of radiation therapy, including treatment for other cancer species.
•2. Patients who have a history of open surgery
•3. Patients who have a history of laparoscopic stomach resection or colectomy
•4. Patients with the latest check values within 14 days before registration meet the following
•Leukocyte <3000 / mm 3,
•Platelet <75,000 / mm 3,
•Hemoglobin <7 G / DL,
•AST> 100 IU / L,
•ALT> 100 IU / L,
•Serum Cr> 1.5 mg / dl.
•5. Other patients who are judged to be unsuitable as a subject by the doctor's judgment.

发起方

Ishibe Atsushi